Floatz logo

IRON DEXTRAN

Anemia, Iron Deficiency

Indiana UniversityOtherPhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

7 Active assets in the Anemia, Iron Deficiency cohort.

Asset / SponsorPhaseRating
FERRIC CATION
Fundación para la Investigación del Hospital Clínico de Valencia
Phase 4A
Iron Isomaltoside
China-Japan Friendship Hospital
Phase 4BBB
IRON(II) SULPHATE (1:1), HEPTAHYDRATE
Linda Malan
Phase 4BBB
SODIUM FERRIC GLUCONATE
Watson Pharmaceuticals
Phase 4BBB
Iron
Cairo University
Phase 4BB

View all 13 →

Same molecule, other indications

IRON DEXTRAN is also rated in:

melanomaDormant
CCC
Indicative ·
48 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →